Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telmisartan vs. Perindopril in Mild-Moderate Alzheimer's Disease
NCT02085265Phase 2Terminated
- Sponsor
- Sunnybrook Health Sciences Centre
- Start
- Mar 2014
- Primary completion
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of telmisartan in Alzheimer's disease (AD), sponsored by Sunnybrook Health Sciences Centre. Started Mar 2014; status: terminated.
02
Drugs
telmisartan
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT02085265.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02085265.